Palm Beach Event Luncheon Event by FON

  • -
Palm Beach Event lunch with Charles Laverty

Palm Beach Event Luncheon Event by FON

We are pleased to announce a Palm Beach event luncheon held by Palm Beach Family Office Association.  The event will take place on November 7th at noon at the Flagler Steakhouse.

The event is Transforming Stenting Best Practice in Coronary Bifurcation Disease.   Our CEO, Charles Laverty will be presenting at the luncheon.

You may RSVP here.


  • -
Charles Laverty will present ABS at the Southern California Investor Conference on August 23rd in Newport Beach

ABS Presenting at SoCal Investor Conference August 23rd

Investors and Entrepreneurs provide the Fuel and Spark for Innovation

Charles Laverty will be accompanied by Ken Richards and others at noon this Thursday, August 23rd at the 2018 Southern California Investor Conference at the Balboa Bay Resort in Newport Beach.

Experts predict that the coronary stent market will reach $10B in 2025 and Bifurcation disease could be 25% of that. As Family Office Networks Founder Andrew Schneider announced recently, “We believe ABS is poised to capture a significant part of this $2.5B market as the only true and complete bifurcating stent delivery platform in the market.”

Conference Details

Southern California Investor Conference
12 noon
Thursday, August 23rd
Balboa Bay Resort, Newport Beach

  • -

Family Office Networks Partners With ABS

FON Says The ABS Platform Will Become The “standard of care”

Family Office Networks announced today a partnership with Advanced Bifurcation Systems (ABS) to introduce its family office members to the ABS platform. Calling our platform a “paradigm shift” in interventional cardiology and saying they expect the ABS platform to become the “standard of care” in the $2.5 billion global bifurcation market.

“ABS represents a great opportunity for family office investors who seek to make a real impact on the future of healthcare. We believe ABS is poised to capture a significant part of this $2.5B market as the only true and complete bifurcating stent delivery platform in the market”

Family Office Networks Founder Andrew Schneider.

 


  • -
MaRS Accepted ABS Canada

MaRs Accepts Advanced Bifurcation Systems Canada

Accepted by MaRS

ABS is very excited to be accepted to join MaRS.  MaRS helps entrepreneurs grow their companies with a comprehensive network of partners.

A quote from their site is “MaRS is the world’s largest urban innovation hub, a place where today’s moonshots become tomorrow’s breakthroughs. It’s a launchpad for startups, a platform for researchers and a home to innovators.”

This Canada based company is found in one of the largest most diverse city in the country.  They are uniquely located to lead in change.  MaRS brings the communities of researchers, social scientists, business experts, and educators all together.

Our company is proud to join these ranks and our full article can be found here.


  • -
Charlie Laverty and Axcessnews

Raising Further Funds Story With Charlie Laverty by Axcessnews

Melissa Thompson of Axcessnews.com did a story with our CEO Charlie Laverty on how we are raising more funds for our company.  These funds will in turn, be life saving for a lot of people.

You can read the full article here.


  • -
Asian Market Strategic Move post by Charles Laverty CEO

Asian Market Sees The Potential

ABS is Making Noise in Asia

We’ve recently begun the next phase of our ongoing growth strategy that will focus on developing plans for the Asian market.  CEO Charles Laverty kicked off this next phase with his recent trip to China.  He met with both medical experts and potential investment partners. The trip was a major success.

Cardiovascular illness is the leading cause of death globally and nowhere is this more evident than in Asia. The Western world had long been considered to have the highest incidents of death from heart disease, but that’s simply no longer true.

1 Out Of 5

In China 1 out of every 5 adults has some form of cardiovascular related illness and those numbers are climbing. It’s part of the global pandemic that’s cutting far too many lives short long before their time. A combination of lifestyle changes and improved medical treatments are needed to curve this problem.

While our initial focus in Asia has been on its largest market in China, this is just phase one of our plans to actively seek partnerships in the Asian market. Cardiovascular disease is a problem that the entire region is struggling to cope with. In Japan for example, the number of people suffering from hypertension is increasing steadily.

Raising Additional Funds in the Asian Market

New approaches are necessary and ABS’s innovative stenting system is a prime example. Our method allows for the placement of stents in both the mother and daughter arteries of a bifurcating lesion at the same time. The procedure is simpler, less time consuming, and more affordable than anything being used today.

In the coming months, we expect to begin the application to the FDA and other regulatory bodies.  In turn, we’ll continue to seek out new partners in Asia and around the globe. Our CEO and board have set a goal of raising an additional $20 million in investment to fund this growth and feels like ABS has huge potential.

Charles Laverty’s trip to China may have started the ball rolling, but it is one more exciting stage in the growth of ABS. The next few months will be an opportunity to continue that momentum and seek out new opportunities.